Navigation Links
QIAGEN and Pfizer Partner to Develop Companion Diagnostic for Novel Compound in Global Clinical Trials for Lung Cancer
Date:8/16/2011

GERMANTOWN, Maryland and HILDEN, Germany, August 16, 2011 /PRNewswire/ --

 

  • Diagnostic-therapeutic combination aims to improve standard of care for patients with non-small cell lung cancer (NSCLC)
  • Molecular test for KRAS gene mutations holds potential to help determine whether there is a subset of patients who are more likely to benefit from Pfizer's investigational anticancer compound
  • Collaboration in lung cancer follows QIAGEN's two FDA submissions of KRAS mutation-based companion diagnostics in metastatic colorectal cancer treatment
  • Partnership builds on QIAGEN's leadership in Personalized Healthcare, with more than 15 co-developments and 20 companion diagnostics

QIAGEN (NASDAQ: QGEN; Frankfurt, Prime Standard: QIA) today announced it has entered into a partnership with Pfizer Inc. (NYSE: PFE) for the development of a companion molecular diagnostic test for use with an investigational Pfizer compound in global clinical development for treatment of non-small cell lung cancer (NSCLC). Financial terms of the agreement were not disclosed.

Pfizer's investigational compound, dacomitinib (PF-00299804), is an oral inhibitor of HER-1 (EGFR), HER-2 and HER-4 tyrosine kinases. The HER (human epidermal growth factor receptor) signaling pathway plays a role in the complex process of cell growth and metastasis, making it a target for anti-cancer drugs.

QIAGEN's proposed companion diagnostic will be based on its proprietary KRAS assay technology, which reliably detects mutations of the KRAS gene that are frequently found in human cancers. Because EGFR inhibitors are generally effective in patients without these KRAS mutations
'/>"/>

SOURCE QIAGEN N.V.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. QIAGEN Completes Second U.S.Submission for Companion Diagnostic to Guide Treatment Decisions in Colorectal Cancer
2. Webcast of QIAGEN N.V.s (Nasdaq: QGEN) Fourth Quarter and Year-End 2009 Financial Results Call Set for February 9
3. QIAGEN Acquires ESE GmbH
4. WuXi AppTec and QIAGEN Enter into Partnership Agreement for Molecular Biomarker Development
5. Ending Cervical Cancer Featured at Summit; QIAGEN CEO Issues a Call to Global Women Leaders
6. Study Finds QIAGENs HPV Test Offers Greater Long-term Protection From Cervical Disease Than the Pap
7. Webcast of QIAGEN N.V.s (Nasdaq: QGEN) First Quarter 2008 Financial Results Call Set for May 6
8. QIAGEN and Center for Molecular Medicine Create Research Collaboration for Molecular Diagnostic Markers for Breast Cancer, Other Womens Health Issues
9. QIAGEN N.V. (Nasdaq: QGEN) Invites You to Join Its Third Quarter 2007 Earnings Conference Call on the Web
10. Pfizer Receives Complete Response Letter from FDA for REMOXY®
11. BioMarin Agrees to Acquire Biologics Manufacturing Plant in Ireland from Pfizer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... 2015 Every year many millions of donations ... disease.  Nevertheless, year after year doctors and the medical ... first test to determine the status of heart health ... not, even though that technology is over 100 years ... doctors know, (while most patients do not know) that ...
(Date:2/26/2015)... MILFORD, Mass. , Feb. 26, 2015 /PRNewswire/ ... developing novel therapeutics for the treatment of Hepatitis ... announced the closing of a $22 million financing. ... of SB 9200, a novel, broad spectrum antiviral ... molecule nucleic acid hybrid (SMNH) chemistry platform, into ...
(Date:2/26/2015)... Calif. , Feb. 26, 2015  Lyric Pharmaceuticals ... A financing round totaling $20.4 million. The financing, co-led ... Ventures, includes participation by Aperture Venture Partners. ... 2013 by David Wurtman , M.D., M.B.A., President ... , M.D., Chief Medical Officer.  In 2014, Lyric closed ...
Breaking Medicine Technology:National Heart Health Month In February 2Spring Bank Pharmaceuticals Completes $22 Million Financing 2
... , - Used during coronary angioplasty plus stenting, ... a new reversible blood thinner did not have a ... of all-cause mortality, heart attack and need for new ... investigational drug significantly lessened the risk for two pre-specified ...
... Md., Nov. 13 The U.S. Food and Drug ... non-hormonal product cleared to treat heavy menstrual bleeding (menorrhagia). ... to clot. , (Logo: http://www.newscom.com/cgi-bin/prnh/20090824/FDALOGO ... year by about 3 million U.S. women of reproductive ...
Cached Medicine Technology:American Heart Association Late-Breaking Clinical Trial Report: New Blood Thinner for Angioplasty Patients Not Superior for Primary Endpoint, but Did Reduce Death and Stent Thrombosis 2American Heart Association Late-Breaking Clinical Trial Report: New Blood Thinner for Angioplasty Patients Not Superior for Primary Endpoint, but Did Reduce Death and Stent Thrombosis 3FDA Approves Lysteda to Treat Heavy Menstrual Bleeding 2
(Date:2/26/2015)... 2015 A Beautiful Smile Dentistry is ... offering the following 50 year celebration specials to their ... of Sonic Care Diamond Clean or the Braun Oral ... The cost is $2895 for the Invisalign special (this ... ten treatment procedures are priced accordingly). The practice ...
(Date:2/26/2015)... 2015 2015 marks five years of ... David Caggiano! , Orthodontics is a perfect blend ... his background in biomedical engineering, his artistic talent, his ... general dentist allows Dr. Caggiano to create innovative approaches ... was named Orthodontic Products’ Best of 2012, a national ...
(Date:2/26/2015)... 2015 The hip resurfacing procedure ... Central Texas resident John Short to resume his active lifestyle, ... out to climb Mt. Kilimanjaro, the highest free-standing mountain in ... , Starting in his late 20s, Short suffered from early ... bones and sockets were bone on bone. , Then ...
(Date:2/26/2015)... Beckman Coulter is sponsoring a new ... cargo in cell-to-cell communication,” which will focus on the ... communication. The webinar is free to attend and will ... , Every cell in the body can release several ... “exosomes” or “microvesicles.” These vesicles carry a wide array ...
(Date:2/26/2015)... Dallas, Texas (PRWEB) February 26, 2015 ... Hemostat Industry is a professional and in-depth study ... Hemostat industry with a focus on the ... market research are Lawton Gmbh & Co.KG, Hu-Friedy, ... Shanghai Medical Instruments, Shuangyin, Shanghai Weirong Medical Equipment, ...
Breaking Medicine News(10 mins):Health News:A Beautiful Smile Dentistry is Celebrating 50 Years in Practice! 2Health News:A Beautiful Smile Dentistry is Celebrating 50 Years in Practice! 3Health News:Dr. David Caggiano of Caggiano Orthodontics is Celebrating Five Years as an "NJ Top Dentist" ! 2Health News:Dr. David Caggiano of Caggiano Orthodontics is Celebrating Five Years as an "NJ Top Dentist" ! 3Health News:Hip Resurfacing at Texas Orthopedics Enables Patient to Climb Mt. Kilimanjaro 2Health News:Hip Resurfacing at Texas Orthopedics Enables Patient to Climb Mt. Kilimanjaro 3Health News:Beckman Coulter Webinar Series Presents Diversity of Extracellular Vesicles and Their Cargo in Cell-to-cell Communication 2Health News:Beckman Coulter Webinar Series Presents Diversity of Extracellular Vesicles and Their Cargo in Cell-to-cell Communication 3Health News:Global Hemostat Industry Data, Size and Growth Report 2015-2020 Now Available at DeepResearchReports.com 2Health News:Global Hemostat Industry Data, Size and Growth Report 2015-2020 Now Available at DeepResearchReports.com 3
... Easter Seals was recently awarded a,$100,000 grant ... support its,workforce development program, Operation Employ Veterans., ... Foundation,s Operation,Healing Freedom campaign, providing training to ... retain wounded veterans across the,Chicagoland area. Area ...
... of Seniors Satisfied with Medicare Drug,Benefit, WASHINGTON, Nov. ... to raise awareness about the 2009,Medicare prescription drug coverage ... 31, 2008., The campaign is designed to encourage ... Part D program if they have not,already done so, ...
... support programs with which Highmark employees ... ... recently awarded,$9,500 to 19 nonprofit organizations in Pennsylvania to support programs,with ... activity, provide nature, arts and culture education,and raise funds to provide ...
... Ten Emerging Technologies That Will Shape Healthcare Next ... ... if a simple blood test could,detect recurrent cancer earlier, while also predicting ... cards could help a,paraplegic breathe without a bulky ventilator. Or imagine if ...
... create predictive models of human disease is likely ... Foundation (ESF), which urged for a collaborative effort ... produces an enormous amount of data from different ... screening of human tissue, and in vitro laboratory ...
... Heart failure patients who regularly exercise fare better ... patients who do not work out on a regular ... The findings, reported today at the annual meeting of ... long way toward addressing concerns about the value of ...
Cached Medicine News:Health News:Easter Seals Awarded $100,000 McCormick Foundation Grant to Help Employ Wounded Veterans 2Health News:Easter Seals Awarded $100,000 McCormick Foundation Grant to Help Employ Wounded Veterans 3Health News:Medicare Today Launches National Medicare Prescription Drug Enrollment Awareness Campaign 2Health News:Medicare Today Launches National Medicare Prescription Drug Enrollment Awareness Campaign 3Health News:Medicare Today Launches National Medicare Prescription Drug Enrollment Awareness Campaign 4Health News:Highmark Employee Volunteers Receive $9,500 in Grants for Nonprofit Organizations 2Health News:Highmark Employee Volunteers Receive $9,500 in Grants for Nonprofit Organizations 3Health News:Highmark Employee Volunteers Receive $9,500 in Grants for Nonprofit Organizations 4Health News:Highmark Employee Volunteers Receive $9,500 in Grants for Nonprofit Organizations 5Health News:Highmark Employee Volunteers Receive $9,500 in Grants for Nonprofit Organizations 6Health News:Cleveland Clinic Unveils 'Top 10' Medical Innovations for 2009 2Health News:Cleveland Clinic Unveils 'Top 10' Medical Innovations for 2009 3Health News:Cleveland Clinic Unveils 'Top 10' Medical Innovations for 2009 4Health News:Cleveland Clinic Unveils 'Top 10' Medical Innovations for 2009 5Health News:Computers make sense of experiments on human disease 2Health News:Computers make sense of experiments on human disease 3Health News:Exercise improves quality of life for heart failure patients 2Health News:Exercise improves quality of life for heart failure patients 3
Stryker Leibinger offers a variety of different Titanium Implant Systems and special instrument sets, which enable our customers to treat a wide range of indication...
Stryker Leibinger offers a variety of different Titanium Implant Systems and special instrument sets, which enable our customers to treat a wide range of indication...
... BiStim provides an effective upgrade path ... of the Magstim 200 modularity. The potential ... paired pulse stimulation through a single stimulating ... and to control independently the power level ...
... Magstim design the new Magstim 200 monophasic ... knowledge and expertise gathered in both the ... innovative design that will help further establish ... of preferred choice. Ergonomic modular approach ...
Medicine Products: